ISRCTN23220202进行中（未招募）1 期
Phase I trial HMR code: 23-006 [The full scientific title will be published within 30 months after the end of the trial]
Gedeon Richter (Hungary)0 个研究点目标入组 168 人开始时间: 2024年2月9日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 168
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Healthy human volunteer
排除标准
- •The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
研究者
相似试验
进行中（未招募）
1 期
Phase I trial HMR code: 23-007The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN10047421Gedeon Richter (Hungary)176
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-011Healthy volunteersISRCTN17328380Asceneuron (Switzerland)16
进行中（未招募）
1 期
Phase I trial HMR code: 23-503The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN70080074xera Pharma UK Ltd220
进行中（未招募）
1 期
Phase I trial, HMR code: 22-016Healthy volunteersISRCTN17231793xera Pharma UK Ltd104
进行中（未招募）
1 期
Phase I trial; HMR code: 24-003Healthy volunteersISRCTN16055614Sling Therapeutics, Inc.20